BioXcel Therapeutics, Inc. (BTAIQ): Form 8-K filed 2026-08-28
- Accepted by EDGAR
- 2026-08-28 06:00 ET
- Event date
- 2026-08-27
- Accession no.
- 0001104659-26-102570
- Original filing
- SEC EDGAR filing index
Items reported
- Item 1.01: Entry into a Material Definitive Agreement
The company signed a material agreement outside the ordinary course of business, or materially amended one. Typical examples are credit agreements, merger agreements, large supply or licensing contracts and financing arrangements. - Item 1.03: Bankruptcy or Receivership
A receiver, fiscal agent or similar officer was appointed for the company or its parent, or the company filed for bankruptcy protection (for example under Chapter 11).
Documents
| Type | Description | Document |
|---|---|---|
| 8-K | FORM 8-K | tm2624233d1_8k.htm |
This page lists what the filing reports; it does not summarize or interpret it. Read the original documents on SEC EDGAR. How to read an 8-K.